Louisiana State Employees Retirement System Lowers Stock Position in UnitedHealth Group Incorporated $UNH

Louisiana State Employees Retirement System decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 3.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 47,900 shares of the healthcare conglomerate's stock after selling 1,600 shares during the period. Louisiana State Employees Retirement System's holdings in UnitedHealth Group were worth $14,943,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. Nuveen LLC bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $3,846,764,000. Vanguard Group Inc. lifted its stake in UnitedHealth Group by 6.6% in the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares during the period. Wellington Management Group LLP lifted its stake in UnitedHealth Group by 10.6% in the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares during the period. National Bank of Canada FI lifted its stake in UnitedHealth Group by 137.8% in the first quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock worth $859,518,000 after acquiring an additional 950,928 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its stake in UnitedHealth Group by 13.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate's stock worth $3,702,736,000 after acquiring an additional 847,054 shares during the period. Institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

UNH has been the subject of several recent research reports. KeyCorp lowered their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Truist Financial raised their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research report on Monday, August 18th. JPMorgan Chase & Co. lowered their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating for the company in a research report on Wednesday, August 6th. Finally, Piper Sandler lowered their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Hold" and a consensus target price of $365.00.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $363.95 on Wednesday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business has a 50-day simple moving average of $311.44 and a two-hundred day simple moving average of $352.42. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $329.62 billion, a price-to-earnings ratio of 15.77, a price-to-earnings-growth ratio of 2.33 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same period last year, the firm posted $6.80 EPS. UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group's payout ratio is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.